James A Solomon
Overview
Explore the profile of James A Solomon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Urso B, Updyke K, Domozych R, Solomon J, Brooks I, Burton V, et al.
Cutis
. 2018 Aug;
102(1):41-43.
PMID: 30138494
Many patients use social media as a source of medical information on dermatologic diseases. Social media offers accessible methods of communicating with physicians, other patients, and pharmacies. The information gathered...
12.
Abuabara K, Asgari M, Chen S, Dellavalle R, Kalia S, Secrest A, et al.
J Am Acad Dermatol
. 2018 Mar;
79(2):400-402.
PMID: 29574090
No abstract available.
13.
Egeberg A, Wu J, Korman N, Solomon J, Goldblum O, Zhao F, et al.
J Am Acad Dermatol
. 2018 Mar;
79(1):104-109.e8.
PMID: 29548945
Background: The impact of ixekizumab treatment for psoriasis on cardiovascular-related parameters in patients is unknown. Objective: To investigate cardiovascular-related parameters in patients with psoriasis treated with ixekizumab. Methods: In phase...
14.
Nergard-Martin J, Caldwell C, Barr M, Dellavalle R, Solomon J
Cutis
. 2018 Mar;
101(1):47.
PMID: 29529106
A new US Food and Drug Administration (FDA) regulation classified tanning beds as class II, requiring indoor tanning facilities to inform users of the risk of skin cancer in efforts...
15.
Caldwell C, Saikaly S, Dellavalle R, Solomon J
J Am Acad Dermatol
. 2017 Oct;
77(5):980-981.
PMID: 29029912
No abstract available.
16.
Tyring S, Solomon J, Staedtler G, Lott J, Nkulikiyinka R, Shakery K
Cutis
. 2016 Nov;
98(4):269-275.
PMID: 27874885
Patient-reported treatment outcomes are important for evaluating the impact of drug therapies on patient experience. A randomized, double-blind, vehicle-controlled, parallel-group, multicenter, phase 3 study was conducted in 961 participants to...
17.
Solomon J, Tyring S, Staedtler G, Sand M, Nkulikiyinka R, Shakery K
Cutis
. 2016 Nov;
98(3):187-194.
PMID: 27814413
Papulopustular rosacea (PPR) is characterized by centrofacial papules and pustules commonly associated with erythema. To compare investigator-reported efficacy outcomes for azelaic acid (AzA) foam 15% versus vehicle foam in PPR,...
18.
Chang A, Lewis K, Arron S, Migden M, Solomon J, Yoo S, et al.
Oncotarget
. 2016 Oct;
7(46):76118-76124.
PMID: 27764798
Because many patients with unresectable basal cell carcinoma (BCC) are aged ≥65 years, this study explores the efficacy and safety of vismodegib in these patients with locally advanced (la) or...
19.
Chang A, Arron S, Migden M, Solomon J, Yoo S, Day B, et al.
Orphanet J Rare Dis
. 2016 Sep;
11(1):120.
PMID: 27581207
Background: Aberrant activation of the Hedgehog (Hh) pathway is a key driver in the pathogenesis of basal cell carcinomas (BCCs), including patients with BCC nevus syndrome (BCCNS). It is unclear...
20.
Kailas A, Solomon J, Mostow E, Rigel D, Kittles R, Taylor S
J Am Acad Dermatol
. 2016 Apr;
74(5):1020-1.
PMID: 27085237
No abstract available.